Exploiting Existing Data Sources To Improve The Prevention And Treatment Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$772,490.00
Summary
My program of research exploits several large databases to answer important issues in the prevention and treatment of cardiovascular disease (CVD), which makes a huge contribution to the burden of illness and premature mortality in Australia. An underlying aim is to provide the evidence base to facilitate improvement of the existing CVD risk assessment guidelines in Australia, for better targeting of clinical advice and treatment.
LoDoCo2 Low Dose Colchicine For Secondary Prevention In Stable Coronary Heart Disease (the LoDoCo2 Trial)
Funder
National Health and Medical Research Council
Funding Amount
$2,399,884.00
Summary
We are conducting clinical trial in several thousand patients to assess the effect of a common, inexpensive and readily available anti-inflammatory drug, colchicine, on heart attack. Colchicine is widely used for treating gout, which is due to inflammation in joints. Since inflammation is an important process makes a cholesterol plaque unstable and can lead to coronary thrombosis and heart attack, we are hypothesising that cholesterol can limit this process.
Identifying The Site/s Of Modification On The Human L-type Ca2+ Channel Protein Isoforms During Oxidative Stress With Reference To Development Of A Therapeutic Target
Funder
National Health and Medical Research Council
Funding Amount
$360,369.00
Summary
A rise in calcium and free radicals in the heart are associated with the development of heart disease. We have good evidence that a protein in the heart muscle known as the L-type calcium channel mediates changes in calcium in response to free radicals. This proposal will identify how the channel function is altered by free radicals so that a therapeutic target can be designed to prevent altered channel function and development of heart disease during increases in free radicals.
Is The Incidence Of Heart Attack Still Decreasing In Australia? Developing More Reliable Methods For Monitoring Trends In Myocardial Infarction And Coronary Heart Disease
Funder
National Health and Medical Research Council
Funding Amount
$762,021.00
Summary
Our study is a collaboration between the University of WA and the Australian Institute of Health and Welfare to investigate population trends in incidence and outcomes of heart disease and its major sub-groups including heart attack, angina and chest pain. Using linked data from WA, we will identify the sub-groups for which trends over time are a realistic estimate of the true population trends. These will be applied to national data to monitor heart disease more accurately in Australia.
TEXTMEDS – TEXT Messages To Improve MEDication Adherence And Secondary Prevention
Funder
National Health and Medical Research Council
Funding Amount
$1,406,875.00
Summary
TEXTMEDS will evaluate a highly innovative strategy to improve cardiovascular disease secondary prevention using cheap and widely available mobile phone technology. TEXTMEDS is a randomised controlled trial of 1400 patients with acute coronary syndrome that will examine the effect of a semi-personalised secondary prevention support program sent via mobile phone text message on the proportion taking appropriate medications for the secondary prevention of cardiovascular disease and on cardiovascul ....TEXTMEDS will evaluate a highly innovative strategy to improve cardiovascular disease secondary prevention using cheap and widely available mobile phone technology. TEXTMEDS is a randomised controlled trial of 1400 patients with acute coronary syndrome that will examine the effect of a semi-personalised secondary prevention support program sent via mobile phone text message on the proportion taking appropriate medications for the secondary prevention of cardiovascular disease and on cardiovascular risk factors levels (e.g. cholesterol).Read moreRead less
The Access Project - Assessment Of Coronary Artery Disease Using CT Effectively For Stable Symptoms
Funder
National Health and Medical Research Council
Funding Amount
$754,369.00
Summary
Invasive Coronary Angiography (ICA) provides x-ray visualisation of coronary disease (CAD) that is essential for coronary surgery/balloon angioplasty. However many patients undergo this procedure without requiring these therapies despite the associated severe complications. The ACCESS Project screens patients scheduled for ICA, identifying those unlikely to have CAD and referring them for non-invasive CT angiography. This strategy reduces procedure complications and result in major cost savings.
The aim of this project is to investigate the burden which is caused by diabetes in people with coronary heart disease, and to determine whether the risk associated with diabetes has increased in recent years. This project will measure the magnitude of this problem, to assist with decision-making about allocation of health resources. The findings will also allow doctors to identify the risk of future acute cardiovascular events such as a heart attack which are associated with having diabetes.
Building Urban Planning And Health Evidence To Inform Policy And Practice That Creates Healthy, Liveable And Equitable Communities Designed To Prevent Non-communicable Diseases
Funder
National Health and Medical Research Council
Funding Amount
$851,980.00
Summary
City planning directly and indirectly affects the health of residents. For example, ‘affordable’ housing on the urban fringe typically has poor access to public transport, shops and services. This increases motor vehicle dependency and time spent driving which increases levels of physical inactivity, sedentariness, obesity, social isolation and air pollution. This research focuses on how to build communities that promote health and wellbeing in residents.
Advancing The Epidemiology Of Coronary Heart Disease: Reliable Monitoring, Secondary Prevention And Future Projections
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
Coronary heart disease imposes a significant health care burden in Australia, and there have been major changes to the way in which this disease is diagnosed and treated. This project will develop a new method for accurate monitoring of the burden of coronary heart disease nationally, will assess the effectiveness of current drug treatments for people with coronary heart disease and estimate future rates of coronary heart disease in the whole population.
Novel Apolipoprotein A-I Mimetic Peptides: A Research Tool And A Therapeutic Agent To Study And Treat Atherosclerosis
Funder
National Health and Medical Research Council
Funding Amount
$266,387.00
Summary
Drugs affecting lipid metabolism have revolutionized the treatment of heart diseases. There is, however, an urgent need for further reduction of high remaining risk. A most promising direction is increasing levels of _good cholesterol�. A new type of such therapy are simple compounds mimicking structure of good cholesterol. We have synthesized new such compounds that are even more active than good cholesterol. Now we will test these compounds in animals and in clinical trial.